PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month
25 sept. 2024 08h30 HE
|
PRISM MarketView
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis
Human Augmentation Market - Forecasts from 2024 to 2029: Advances in AI, Biotechnology, Nanotechnology, Robotics, and Materials Science Fueling Developments
23 sept. 2024 07h26 HE
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Human Augmentation Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The human augmentation market is...
Pharmaceuticals and Biotechnology Option and Evaluation Deal Trends Report 2024 with Directory of Deals Signed Since 2016
23 sept. 2024 06h41 HE
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Option and...
Keck Graduate Institute Awarded $750,000 Grant from the Department of Energy to Study Low-Level Radiation Effects
19 sept. 2024 14h34 HE
|
Keck Graduate Institute
Claremont, CA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Keck Graduate Institute (KGI), a member of The Claremont Colleges, has been awarded a significant grant from the Department of Energy to investigate...
Thought Leadership & Innovation Foundation Proudly Accepts Ownership of Limb Loss and Preservation Registry in Collaboration with Amputee Coalition
18 sept. 2024 13h38 HE
|
Thought Leadership & Innovation Foundation
McLEAN, Va., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI), a not-for-profit organization that works at the nexus of science, technology and public health,...
John Snow Labs Awarded Phase I SBIR Contract for the Development of Medical Large Language Models for Infectious and Immune-Mediated Diseases
17 sept. 2024 09h00 HE
|
John Snow Labs
John Snow Labs has been awarded an SBIR Phase I contract from NIAID for the development of medical LLMs for infectious and immune-mediated diseases.
Thought Leadership & Innovation Foundation Announces Gala to Initiate Development of Patient Portal for Age-Related Macular Degeneration
16 sept. 2024 10h00 HE
|
Thought Leadership & Innovation Foundation
Thought Leadership & Innovation Foundation, American Macular Degeneration Foundation Announce Gala Event to Support AMD Patient Portal Development
Thought Leadership & Innovation Foundation (TLI) Announces Partnership with OneStep to Advance Data-Driven Research in Limb Loss and Preservation
12 sept. 2024 10h00 HE
|
Thought Leadership & Innovation Foundation
TLI Partners with OneStep: Advanced Gait Analysis Technology Enhances Limb Loss and Preservation Registry with Insights into Patient Mobility
India Pharmaceutical Industry Research 2024: $105+ Billion Market Trends, Regional Insights, Competition, Forecasts and Opportunities, 2020-2030
11 sept. 2024 11h50 HE
|
Research and Markets
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "India Pharmaceutical Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
Vaping Expected to Increase COPD Health and Economic Burden by 2050
10 sept. 2024 08h00 HE
|
ResMed Inc.
Vaping Expected to Increase COPD Health and Economic Burden by 2050
New ResMed-supported research presented at ERS 2024